We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

53 hedge funds and large institutions have $24.5M invested in Redhill Biopharma in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $4.3M | Put options by funds: $1.84M

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

10% more funds holding

Funds holding: 48 → 53 (+5)

0% less ownership

Funds ownership: 0% → 0% (-0%)

50% less capital invested

Capital invested by funds: $49.1M → $24.5M (-$24.6M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
15
Reduced
11
Closed
9
Calls
$4.3M
Puts
$1.84M
Net Calls
+$2.45M
Net Calls Change
+$415K

Top Buyers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$522K
2
Group One Trading
Group One Trading
Illinois
+$461K
3
GS
Gagnon Securities
New York
+$332K
4
JP Morgan Chase
JP Morgan Chase
New York
+$298K
5
Citadel Advisors
Citadel Advisors
Florida
+$271K

Top Sellers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
-$5.21M
2
DCM
DAFNA Capital Management
California
-$3.14M
3
SM
Sabby Management
Florida
-$2.34M
4
II
Ibex Investors
Colorado
-$1.74M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
Ancora Advisors
Ohio
$172K +$258K +38 New
Morgan Stanley
27
Morgan Stanley
New York
$156K -$67.8K -10 -23%
ISL
28
Ingalls & Snyder LLC
New York
$133K +$67.8K +10 +53%
CAAS
29
Capital Asset Advisory Services
Michigan
$132K +$197K +29 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$124K – – –
Jane Street
31
Jane Street
New York
$123K +$40.7K +6 +29%
TRCT
32
Tower Research Capital (TRC)
New York
$123K +$163K +24 +800%
Mercer Global Advisors
33
Mercer Global Advisors
Colorado
$119K – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$110K +$122K +18 +300%
CSS
35
Cubist Systematic Strategies
Connecticut
$92K +$136K +20 New
AIM
36
ARK Investment Management
Florida
$88K -$5.21M -768 -98%
VF
37
Virtu Financial
New York
$88K +$129K +19 New
WDC
38
Woodward Diversified Capital
California
$78K -$149K -22 -56%
DADC
39
D.A. Davidson & Co
Montana
$77K -$88.2K -13 -43%
PF
40
Phoenix Financial
Israel
$75K +$115K +17 New
Bank of America
41
Bank of America
North Carolina
$69K +$47.5K +7 +88%
HF
42
HRT Financial
New York
$57K +$88.2K +13 New
Commonwealth Equity Services
43
Commonwealth Equity Services
Massachusetts
$53K +$81.4K +12 New
CIBC World Market
44
CIBC World Market
Ontario, Canada
$51K – – –
SPIA
45
Steward Partners Investment Advisory
New York
$34K – – –
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$25K – – –
CFGS
47
Concourse Financial Group Securities
Alabama
$17K +$27.1K +4 New
CG
48
Cutler Group
California
$17K +$27.1K +4 New
Citigroup
49
Citigroup
New York
$11K -$6.78K -1 -33%
BWA
50
BDO Wealth Advisors
Florida
$5K – – –
1
2
3

RDHL Hedge Fund Activity: Q3 2021 in Review

53 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2021, worth a combined $24.5M — down 50% from $49.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RDHL positions and 9 closed out — a net gain of 6 holders — while 15 added to existing stakes and 11 trimmed.

The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $522K. The largest seller was ARK Investment Management, cutting an estimated $5.21M.

  • 53 institutional investors held Redhill Biopharma (RDHL) as of Q3 2021, up from 48 in Q2 2021.
  • Funds reported $24.5M of Redhill Biopharma stock for Q3 2021, down 50% quarter-over-quarter.
  • 15 funds opened new Redhill Biopharma positions in Q3 2021 and 9 closed out, a net change of +6 holders.
  • The largest Redhill Biopharma buyer in Q3 2021 was Envestnet Asset Management, an estimated $522K added.
  • The largest Redhill Biopharma seller in Q3 2021 was ARK Investment Management, an estimated $5.21M sold.

Based on aggregated 13F filings for Q3 2021.